239 related articles for article (PubMed ID: 25266736)
1. Comprehensive genomic profiling of pancreatic acinar cell carcinomas identifies recurrent RAF fusions and frequent inactivation of DNA repair genes.
Chmielecki J; Hutchinson KE; Frampton GM; Chalmers ZR; Johnson A; Shi C; Elvin J; Ali SM; Ross JS; Basturk O; Balasubramanian S; Lipson D; Yelensky R; Pao W; Miller VA; Klimstra DS; Stephens PJ
Cancer Discov; 2014 Dec; 4(12):1398-405. PubMed ID: 25266736
[TBL] [Abstract][Full Text] [Related]
2. RAF1 rearrangements are common in pancreatic acinar cell carcinomas.
Prall OWJ; Nastevski V; Xu H; McEvoy CRE; Vissers JHA; Byrne DJ; Takano E; Yerneni S; Ellis S; Green T; Mitchell CA; Murray WK; Scott CL; Grimmond SM; Hofmann O; Papenfuss A; Kee D; Fellowes A; Brown IS; Miller G; Kumarasinghe MP; Perren A; Nahm CB; Mittal A; Samra J; Ahadi M; Fox SB; Chou A; Gill AJ
Mod Pathol; 2020 Sep; 33(9):1811-1821. PubMed ID: 32358589
[TBL] [Abstract][Full Text] [Related]
3. A FISH assay efficiently screens for BRAF gene rearrangements in pancreatic acinar-type neoplasms.
Wang L; Basturk O; Wang J; Benayed R; Middha S; Zehir A; Linkov I; Rao M; Aryeequaye R; Cao L; Chmielecki J; Ross J; Stephens PJ; Adsay V; Askan G; Balci S; Klimstra DS
Mod Pathol; 2018 Jan; 31(1):132-140. PubMed ID: 28884748
[TBL] [Abstract][Full Text] [Related]
4. Oncogenic FAM131B-BRAF fusion resulting from 7q34 deletion comprises an alternative mechanism of MAPK pathway activation in pilocytic astrocytoma.
Cin H; Meyer C; Herr R; Janzarik WG; Lambert S; Jones DT; Jacob K; Benner A; Witt H; Remke M; Bender S; Falkenstein F; Van Anh TN; Olbrich H; von Deimling A; Pekrun A; Kulozik AE; Gnekow A; Scheurlen W; Witt O; Omran H; Jabado N; Collins VP; Brummer T; Marschalek R; Lichter P; Korshunov A; Pfister SM
Acta Neuropathol; 2011 Jun; 121(6):763-74. PubMed ID: 21424530
[TBL] [Abstract][Full Text] [Related]
5. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
Ross JS; Wang K; Chmielecki J; Gay L; Johnson A; Chudnovsky J; Yelensky R; Lipson D; Ali SM; Elvin JA; Vergilio JA; Roels S; Miller VA; Nakamura BN; Gray A; Wong MK; Stephens PJ
Int J Cancer; 2016 Feb; 138(4):881-90. PubMed ID: 26314551
[TBL] [Abstract][Full Text] [Related]
6. AGAP3: A novel BRAF fusion partner in pediatric pancreatic-type acinar cell carcinoma.
Paoli C; Burel-Vandenbos F; Coulomb-l'Hermine A; Cros J; Pondrom M; Kubiniek V; Pedeutour F; Dadone-Montaudié B
Genes Chromosomes Cancer; 2022 Dec; 61(12):734-739. PubMed ID: 35949061
[TBL] [Abstract][Full Text] [Related]
7. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
[TBL] [Abstract][Full Text] [Related]
8. Pancreatic acinar cell carcinoma: A review on molecular profiling of patient tumors.
Al-Hader A; Al-Rohil RN; Han H; Von Hoff D
World J Gastroenterol; 2017 Dec; 23(45):7945-7951. PubMed ID: 29259370
[TBL] [Abstract][Full Text] [Related]
9. RET gene rearrangements occur in a subset of pancreatic acinar cell carcinomas.
Chou A; Brown IS; Kumarasinghe MP; Perren A; Riley D; Kim Y; Pajic M; Steinmann A; Rathi V; Jamieson NB; Verheij J; van Roessel S; Nahm CB; Mittal A; Samra J; Gill AJ
Mod Pathol; 2020 Apr; 33(4):657-664. PubMed ID: 31558784
[TBL] [Abstract][Full Text] [Related]
10. BRAF Rearrangements and BRAF V600E Mutations Are Seen in a Subset of Pancreatic Carcinomas With Acinar Differentiation.
Ghosh T; Greipp PT; Knutson D; Kloft-Nelson S; Jenkins S; Mounajjed T; Said S; La Rosa S; Vanoli A; Sessa F; Naini BV; Bellizzi A; Zhang L; Kerr SE; Graham RP
Arch Pathol Lab Med; 2022 Jul; 146(7):840-845. PubMed ID: 34614142
[TBL] [Abstract][Full Text] [Related]
11. Successful BRAF/MEK inhibition in a patient with
Busch E; Kreutzfeldt S; Agaimy A; Mechtersheimer G; Horak P; Brors B; Hutter B; Fröhlich M; Uhrig S; Mayer P; Schröck E; Stenzinger A; Glimm H; Jäger D; Springfeld C; Fröhling S; Zschäbitz S
Cold Spring Harb Mol Case Stud; 2020 Aug; 6(4):. PubMed ID: 32843432
[TBL] [Abstract][Full Text] [Related]
12. BRAF gene rearrangements can be identified by FISH studies in pancreatic acinar cell carcinoma.
Chou A; Kim Y; Samra JS; Pajic M; Gill AJ
Pathology; 2018 Apr; 50(3):345-348. PubMed ID: 29506751
[No Abstract] [Full Text] [Related]
13. Genomic Profiling Reveals Germline Predisposition and Homologous Recombination Deficiency in Pancreatic Acinar Cell Carcinoma.
Mandelker D; Marra A; Zheng-Lin B; Selenica P; Blanco-Heredia J; Zhu Y; Gazzo A; Wong D; Yelskaya Z; Rai V; Somar J; Ostafi S; Mehta N; Yang C; Li Y; Brown DN; da Silva EM; Pei X; Linkov I; Terraf P; Misyura M; Ceyhan-Birsoy O; Ladanyi M; Berger M; Pareja F; Stadler Z; Offit K; Riaz N; Park W; Chou J; Capanu M; Koehler M; Rosen E; O'Reilly EM; Reis-Filho JS
J Clin Oncol; 2023 Nov; 41(33):5151-5162. PubMed ID: 37607324
[TBL] [Abstract][Full Text] [Related]
14. Retrospective Case Series Analysis of
Hendifar A; Blais EM; Wolpin B; Subbiah V; Collisson E; Singh I; Cannon T; Shaw K; Petricoin EF; Klempner S; Lyons E; Wang-Gillam A; Pishvaian MJ; O'Reilly EM
JCO Precis Oncol; 2021; 5():. PubMed ID: 34476331
[TBL] [Abstract][Full Text] [Related]
15. Near complete remission of an inoperable pancreatic acinar cell carcinoma after BRAF-/MEK-inhibitor treatment-A case report and review of the literature.
von Fritsch L; von Bubnoff N; Weber K; Kirfel J; Schreiber C; Keck T; Wellner U
Genes Chromosomes Cancer; 2024 Feb; 63(2):e23222. PubMed ID: 38340027
[TBL] [Abstract][Full Text] [Related]
16. Identification of frequent BRAF copy number gain and alterations of RAF genes in Chinese prostate cancer.
Ren G; Liu X; Mao X; Zhang Y; Stankiewicz E; Hylands L; Song R; Berney DM; Clark J; Cooper C; Lu YJ
Genes Chromosomes Cancer; 2012 Nov; 51(11):1014-23. PubMed ID: 22833462
[TBL] [Abstract][Full Text] [Related]
17. Germline BRCA2 variants in advanced pancreatic acinar cell carcinoma: A case report and review of literature.
Lee CL; Holter S; Borgida A; Dodd A; Ramotar S; Grant R; Wasson K; Elimova E; Jang RW; Moore M; Kim TK; Khalili K; Moulton CA; Gallinger S; O'Kane GM; Knox JJ
World J Gastroenterol; 2022 Dec; 28(45):6421-6432. PubMed ID: 36533108
[TBL] [Abstract][Full Text] [Related]
18. Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC.
Florou V; Elliott A; Bailey MH; Stone D; Affolter K; Soares HP; Nevala-Plagemann C; Scaife C; Walker P; Korn WM; Lou E; Shroff RT; Hosein PJ; Garrido-Laguna I
Clin Cancer Res; 2023 Sep; 29(17):3408-3417. PubMed ID: 37266563
[TBL] [Abstract][Full Text] [Related]
19. B-Raf is required for ERK activation and tumor progression in a mouse model of pancreatic beta-cell carcinogenesis.
Sobczak I; Galabova-Kovacs G; Sadzak I; Kren A; Christofori G; Baccarini M
Oncogene; 2008 Aug; 27(35):4779-87. PubMed ID: 18490924
[TBL] [Abstract][Full Text] [Related]
20. Cytomorphologic, immunophenotypical and molecular features of pancreatic acinar cell carcinoma.
Sun T; Gilani S; Jain D; Cai G
Diagn Cytopathol; 2023 Nov; 51(11):674-683. PubMed ID: 37469257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
